10-Day Study Start & Custom Test Kit Build at the Height of a Pandemic

Cerba Research initiated custom kit building & distribution for an infectious disease study, during the COVID-19 pandemic, in 10 days. A typical timeline is 8 weeks.

Phase 3 Clinical Trial on the Efficacy and Safety of a New Therapy For Post-Exposure Prophylaxis Of COVID-19 And Other Viral Respiratory Illnesses

Phase 3 Clinical Trial on the Safety and Efficacy Of Combination Therapies in Patients with Either Extensively Drug-Resistant Tuberculosis (XDR-TB), Pre-XDR-TB Or Treatment Intolerant Or Non- Responsive Multi-Drug Resistant Tuberculosis (MDR-TB)

Phase 3 Clinical Trial on the Efficacy and Safety of a New Therapy in the Treatment of Uncomplicated Influenza

Multiple Myeloma – Efficacy and Safety of 2 Different Combination Therapies

COVID-19 Testing at Cerba Research

Fact Sheet – Oncology Clinical Trials at Cerba Research

Fact Sheet – NASH Clinical Trials at Cerba Research

Fact Sheet – Clinical Trials at Cerba Research

Fact Sheet – Clinical Trials Autoimmune Diseases at Cerba Research